Search NASA⌕ Search

SEARCH · Search NASA

Results for “Dose Code”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,585 records · Page 88

SU-E-T-586: Field Size Dependence of Output Factor for Uniform Scanning Proton Beams: A Comparison of TPS Calculation, Measurement and Monte Carlo Simulation

Purpose: Output dependence on field size for uniform scanning beams, and the accuracy of treatment planning system (TPS) calculation are not well studied. The purpose of this work is to investigate the dependence of output on field size for uniform scanning beams and compare it among TPS calculation, measurements and Monte Carlo simulations. Methods: Field size dependence was studied using various field sizes between 2.5 cm diameter to 10 cm diameter. The field size factor was studied for a number of proton range and modulation combinations based on output at the center of spread out Bragg peak normalized to a 10 cm diameter field. Three methods were used and compared in this study: 1) TPS calculation, 2) ionization chamber measurement, and 3) Monte Carlos simulation. The XiO TPS (Electa, St. Louis) was used to calculate the output factor using a pencil beam algorithm; a pinpoint ionization chamber was used for measurements; and the Fluka code was used for Monte Carlo simulations. Results: The field size factor varied with proton beam parameters, such as range, modulation, and calibration depth, and could decrease over 10% from a 10 cm to 3 cm diameter field for a large range proton beam. The XiO TPS predicted the field size factor relatively well at large field size, but could differ from measurements by 5% or more for small field and large range beams. Monte Carlo simulations predicted the field size factor within 1.5% of measurements. Conclusion: Output factor can vary largely with field size, and needs to be accounted for accurate proton beam delivery. This is especially important for small field beams such as in stereotactic proton therapy, where the field size dependence is large and TPS calculation is inaccurate. Measurements or Monte Carlo simulations are recommended for output determination for such cases.

07 ISOTOPE AND RADIATION SOURCES↗

SU-E-T-593: Outcomes and Toxicities From a Clinical Trial of APBI Using MERT+IMRT with the Same XMLC

Purpose: We present the results from a clinical trial of accelerated partial breast irradiation (APBI), using mixed modulated photon and electron beams (MERT+IMRT) with the same photon multileaf collimator (xMLC). Methods: Seven patients were enrolled in the first year of the APBI clinical trial. Patients were selected following the conditions included in the NSABP B-39/RTOG 0413 protocol. The targets and clinically relevant normal structures were contoured on the CT images following this protocol for APBI-EBRT. All treatments were delivered using combined modulated electron and photon beams by means of the same xMLC installed in a SIEMENS Primus linac, with a reduced SSD equal to 60 cm for electron beams. The plans were performed with a treatment planning system based on full Monte Carlo simulations, called CARMEN, developed by our group. Simultaneously, an alternative IMRT plan was calculated with the commercial TPS PINNACLE v8.0m (Philips), and both plans were compared. An ad-hoc breast phantom with semi-spherical geometry called NAOMI was designed for a specific QA protocol. Patients received a total dose of 38.5 Gy, delivered in 10 fractions over 5 consecutive days, with a twice-a-day hypofractionated schema.Follow-up visits during 2.5 years on average were repeated at 1 month post-treatment, every 3 months for the first year, and every 6 months for the second year. Toxicity was scored according to National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE version 3.0). Results: This APBI technique achieved high loco-regional control rates and showed low acute toxicity (grade 1 of CTCAE) and no toxicities from first month onwards. Photographic assessment of cosmesis showed skin excellent results. Conclusion: The clinical results achieved with MERT+IMRT by using the same xMLC are comparable or even better than those obtained with other APBI techniques, thanks to a software solution without any additional equipment or specific device.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

SU-F-T-556: A Potential Real Time AQA for Cyberknife Cones and MLC Based Treatments

Purpose: To investigate the potential use of the Raven™ (LAP of America Laser Applications) for real time AQA of Cyberknife™ with InCise2 MLC (Accuray™ Medical). Methods: At setup, the Raven was rotated 45° on which an Accuray™ AQA cube was positioned. Three different AQA plans for fixed cone, InCise2MLC, and a modified MLC plan were delivered repeatedly ten times. The additional shapes in modified AQA plan enable additional reproducibility checks for all the MLC pairs. During the test, the cube was aligned by imbedded fiducials and irradiated. The two angled radiation beams aimed center tungsten ball of the cube and projected 45° to phosphor screen and registered by a CCD camera of the Raven device. The centricity of the metal ball in the irradiated field was then analyzed using Matlab codes. Results: For AP images, the average offsets of X, Y, and radial directions are 0.24 ± 0.04 mm, 0.25 ± 0.02 mm and 0.35 ±± 0.03 mm respectively for the cone; 0.34 ± 0.02 mm, 0.49 ± 0.04 mm and 0.60 ± 0.04 mm respectively for the MLC. For lateral images, they are 0.63 ± 0.05 mm, 0.11 ± 0.02 mm and 0.64 ± 0.04 mm respectively for the cone, 0.79 ± 0.08 mm, −0.23 ± 0.06 mm and 0.82 ± 0.09 mm respectively for the MLC. No inconsistent MLC shapes were found in the modified AQA group. Conclusion: The results are consistent with clinically acceptable values (≤1mm from baseline). The results suggest the potential of replacement of the standard AQA test with the novel real-time Raven device for Cyberknife daily QA. The modified MLC based AQA provides a more comprehensive MLC daily QA capability. Further improvements in its resolution and automatic analyzing capability are warranted.

60 APPLIED LIFE SCIENCES↗

SU-E-T-407: Evaluation of Four Commercial Dosimetry Systems for Routine Patient-Specific Tomotherapy Delivery Quality Assurance

Purpose: The purpose of this project was to evaluate the performance of four commercially available dosimetry systems for Tomotherapy delivery quality assurance (DQA). Methods: Eight clinical patient plans were chosen to represent a range of treatment sites and typical clinical plans. Four DQA plans for each patient plan were created using the TomoTherapy DQA Station (Hi-Art version 4.2.1) on CT images of the ScandiDose Delta4, IBA MatriXX Evolution, PTW Octavius 4D and Sun Nuclear ArcCHECK phantoms. Each detector was calibrated following the manufacture-provided procedure. No angular response correction was applied. All DQA plans for each detector were delivered on the Tomotherapy Hi-Art unit in a single measurement session but on different days. The measured results were loaded into the vendor supplied software for each QA system for comparison with the TPS-calculated dose. The Gamma index was calculated using 3%/3mm, 2%/2mm with 10% dose threshold of maximum TPS calculated dose. Results: Four detector systems showed comparable gamma pass rates for 3%/3m, which is recommended by AAPM TG119 and commonly used within the radiotherapy community. The averaged pass rates ± standard deviation for all DQA plans were (98.35±1.97)% for ArcCHECK, (99.9%±0.87)% for Matrix, (98.5%±5.09)% for Octavius 4D, (98.7%±1.27)% for Delata4. The rank of the gamma pass rate for individual plans was consistent between detectors. Using 2%/2mm Gamma criteria for analysis, the Gamma pass rate decreased on average by 9%, 8%, 6.6% and 5% respectively. Profile and Gamma failure map analysis using the software tools from each dosimetry system indicated that decreased passing rate is mainly due to the threading effect of Tomo plan. Conclusion: Despite the variation in detector type and resolution, phantom geometry and software implementation, the four systems demonstrated similar dosimetric performance, with the rank of the gamma pass rate consistent for the plans considered.

60 APPLIED LIFE SCIENCES↗

SU-C-201-07: Towards Clinical Cherenkov Emission Dosimetry: Stopping Power-To-Cherenkov Power Ratios and Beam Quality Specification of Clinical Electron Beams

Purpose: We propose a Cherenkov emission (CE)-based reference dosimetry method, which in contrast to ionization chamber-based dosimetry, employs spectrum-averaged electron restricted mass collision stopping power-to-Cherenkov power ratios (SCRs), and we examine Monte Carlo-calculated SCRs and beam quality specification of clinical electron beams. Methods: The EGSnrc user code SPRRZnrc was modified to compute SCRs instead of stopping-power ratios (single medium: water; cut-off: CE threshold (observing Spencer-Attix conditions); CE power: Frank-Tamm). SCRs are calculated with BEAMnrc for realistic electron beams with nominal energies of 6–22 MeV from three Varian accelerators (TrueBeam Clinac 21EX, Clinac 2100C/D) and for mono-energetic beams of energies equal to the mean electron energy at the water surface. Sources of deviation between clinical and mono-energetic SCRs are analyzed quantitatively. A universal fit for the beam-quality index R{sub 50} in terms of the depth of 50% CE C{sub 50} is carried out. Results: SCRs at reference depth are overestimated by mono-energetic values by up to 0.2% for a 6-MeV beam and underestimated by up to 2.3% for a 22-MeV beam. The variation is mainly due to the clinical beam spectrum and photon contamination. Beam angular spread has a small effect across all depths and energies. The influence of the electron spectrum becomes increasingly significant at large depths, while at shallow depths and high beam energies photon contamination is predominant (up to 2.0%). The universal data fit reveals a strong linear correlation between R{sub 50} and C{sub 50} (ρ > 0.99999). Conclusion: CE is inherent to radiotherapy beams and can be detected outside the beam with available optical technologies, which makes it an ideal candidate for out-of-beam high-resolution 3D dosimetry. Successful clinical implementation of CE dosimetry hinges on the development of robust protocols for converting measured CE to radiation dose. Our findings constitute a key step towards clinical CE dosimetry.

60 APPLIED LIFE SCIENCES↗

Experiment Design of Secondary Neutron and Charged Particles Measurement with Stopping Targets Bombarded by 100- and 230-MeV/amu Helium Ions - Paper 124

Radiotherapy using ion beams has gained momentum in radiation oncology. While the number of proton therapy facilities that have been established or are under construction is rapidly growing, interest in heavy ion (whose atomic number Z is greater than one) radiotherapy has also been revitalized in the U.S. Helium ions, with mass and charge between protons and carbon ions, have advantages of deep penetration distances with significant peak-to-entrance dose ratios and limited dose contributions from secondary neutrons and other secondary charged fragments. In consideration of these advantages, the U.S. ion beam therapy community has expressed interests in helium ions as a potential candidate for ion beam therapy, especially pediatric cases. As such, characterizing the secondary nuclear fragment field created by primary helium ion interactions along the beam delivery devices and in human tissue is important for dose assessment and patient protection. Up to now the experimental data with respect to helium ions over the therapeutic energy range, 100 - 230 MeV/amu, is scarce compared to protons and carbon ions. Kurosawa et al. measured stopping target yields and angular spectra of neutrons, protons, deuterons and tritons produced by various target materials bombarded by 100- and 180- MeV/amu helium ions; Heilbronn et al. and Cecil et al. also measured the stopping target neutron yields by 155-, 160- and 177.5-MeV/amu helium ion bombardments. We have proposed to measure angular distributions of secondary neutrons and light charged ions produced by 100- and 230-MeV/amu helium ions bombarding stopping water and iron targets. The experiment was conducted at the Heavy Ion Medical Accelerator in Chiba (HIMAC) of the National Institute of Radiological Sciences (NIRS) in Japan this June. During the literature survey for experimental setup, we found that the ratio of the ion beam range (R) to the target depth (d) varies from 0.5 - 0.98 in the stopping target measurements either for helium ions incident on various targets or carbon ions bombarding targets as tissue surrogates. The difference in the values of ratio R/d makes comparison of experimental results complicated and require accurate corrections. Hence, how the R/d ratio and cross sectional area of the targets influence the angular distributions of secondary particles is investigated by using a Monte Carlo method in this study. The influence of the depth and the cross sectional area of stopping water and iron targets on the yield and the spectra of secondary particles induced by 100- and 230-MeV/amu He ions was studied by a Monte Carlo simulation code, PHITS. The secondary charged particles and secondary neutrons who come from breakup of projectiles are highly forward-focused, while the secondary particles produced by target breakup are nearly isotropic. As the energy of {sup 4}He ions increases from 100 MeV/amu to 230 MeV/amu, the normalized intensities of charged particles decrease more gently with increasing angles, whereas the neutron angular distribution falls quickly at angles smaller than 30 deg. and starts to exceed the normalized profile of 100 MeV/amu He from 60 deg. When the target depth increases, the impact on attenuation of secondary particles is more significant for lighter target mass and higher-energy projectiles at forward angles. Also, with deeper targets, more interactions occur between the secondary particles and the target elements, which results in more target-like fragments at large and backward angles. In respect of the cross sectional area of the stopping targets, the forward angular distributions are similar to the system with smaller cross sectional area of the targets; however, no general rule was found for how the large-angle distributions are affected by the target cross sectional area. (authors)

61 RADIATION PROTECTION AND DOSIMETRY↗

Heating effects on jack pine pyrogenic organic matter properties from a pyrocosm study in 2022

This dataset contains data associated with the preprint “Fire removes preexisting pyrogenic organic matter from the ecosystem through the mechanisms of both direct combustion and increasing mineralizability” (Luo et al., 2025b), which is the complementary study to the published paper “Reburning pyrogenic organic matter: a laboratory method for dosing dynamic heat fluxes from above” (Luo et al., 2025a). We designed a full-factorial experiment with different burial depths of jack pine (Pinus banksiana Lamb) pyrogenic organic matter (PyOM) (Surface, 1 cm, and 5 cm) and different heat-flux profiles (High, Low, and Control) to examine how subsequent fires affect the properties of preexisting PyOM. We measured total carbon (C), pH, dissolved organic carbon (DOC), dissolved inorganic carbon (DIC), and mineralized C (as CO₂-C, from a 12-week incubation).We found that high heat flux and/or surface placement resulted in substantial direct C losses through combustion. Intermediate heat exposure produced both combustion losses and increases in DOC and mineralizability, which may have complex long-term implications: an increased dissolved fraction of PyOM may promote downward transport into mineral soils and potentially contribute to deeper, longer-term C storage, but it may also make PyOM more susceptible to microbial decomposition. Under the lowest heat flux and deepest burial, most PyOM was retained, and changes in DOC and C mineralization were minimal. Finally, PyOM pH, an important chemical property, decreased under low-temperature heating but increased under higher temperatures.We uploaded pH data for all samples (“pH_of_all_samples.csv”); pH and temperature-related data (peak temperature and degree hours) for samples in High and Low heat-flux treatments (“pH_vs_peakT_and_degree_hours_only_for_heated_samples.csv”); total C data (“CN_pct_C_stock_C_loss_in_samples.csv”); DOC and DIC data (“doc_dic.csv”); and mineralized C (CO₂-C) data (“CO2-C_all_original.csv”). Additional details can be found in the Methods & Sampling section.All datasets uploaded to ESS-DIVE are clearly labeled, cleaned, and include both raw and derived data, ready for reuse in other analyses. All analysis code and raw datasets are also available on GitHub: https://github.com/MengmengLuo/Fire-removes-preexisting-pyrogenic-organic-matter-from-the-ecosystem.

54 ENVIRONMENTAL SCIENCES↗

TU-PIS-Exhibit Hall-1: Therapy: Deformable Image Registration, Contour Propagation, and Dose Mapping

Brachytherapy devices and software are designed to last for a certain period of time. Due to a number of considerations, such as material factors, wear-and-tear, backwards compatibility, and others, they all reach a date when they are no longer supported by the manufacturer. Most of these products have a limited duration for their use, and the information is provided to the user at time of purchase. Because of issues or concerns determined by the manufacturer, certain products are retired sooner than the anticipated date, and the user is immediately notified. In these situations, the institution is facing some difficult choices: remove these products from the clinic or perform tests and continue their usage. Both of these choices come with a financial burden: replacing the product or assuming a potential medicolegal liability. This session will provide attendees with the knowledge and tools to make better decisions when facing these issues. Learning Objectives: Understand the meaning of “end-of-life or “life expectancy” for brachytherapy devices and software Review items (devices and software) affected by “end-of-life” restrictions Learn how to effectively formulate “end-of-life” policies at your institution Learn about possible implications of “end-of-life” policy Review other possible approaches to “end-of-life” issue.

60 APPLIED LIFE SCIENCES↗

Summary of Analytical Services for the Hanford Site Radionuclide NESHAP Program

This document is a summary of the point source analytical requirements used to demonstrate compliance for the Department of Energy (DOE) Hanford Site operations with 40 Code of Federal Regulations (CFR) Part 61, “National Emission Standards for Hazardous Air Pollutants,” (NESHAP) Subpart H, “National Emission Standards for Emissions of Radionuclides Other Than Radon From Department of Energy Facilities,” and the Washington Administrative Code (WAC) 246-247, “Radiation Protection – Air Emissions.” This reference collects information from multiple source documents and is not intended to create, supersede, replace or over-ride any existing contractual, DOE, federal or state statutes, regulations, compliance agreements, orders, permits, licenses or other requirements. The requirement source document governs where any difference may exist. The Hanford Mission Integration Solutions (HMIS) Environmental organization has been contracted by DOE to manage and report data collected from the sampling and monitoring of radioactive air emissions point sources, colloquially called stacks. The Environmental organization coordinates the analyses and reporting of samples collected at various facilities across the Hanford Site. These facilities operate approximately 52 stacks that require sampling, monitoring or estimating radioactive air emissions. The stacks are operated by Bechtel National, Inc. (BNI), Central Plateau Cleanup Company (CPCCo), Hanford Tank Waste Operations & Closure (H2C), Hanford Laboratory Management and Integration (HLMI), and Pacific Northwest National Laboratory (PNNL). Stack samples from CPCCo, HLMI and H2C facilities are collected by the operating contractor staff, delivered to HMIS, and then shipped to an offsite contracted laboratory for analyses. The field and laboratory sample data uploaded into the Sample Management and Analytical Results Tracking (SMART) database are used to calculate sample volumes and concentrations. Sample concentrations are evaluated for compliance with federal and state regulations, permits, and license requirements. The SMART database also calculates total curies released for sampled point sources and stacks. Point source effluent concentrations and releases are published annually in publicly available reports. The BNI and PNNL operate several DOE-Hanford Field Office (HFO) stacks subject to the requirements of 40 CFR 61, Subpart H and WAC 246-247. The concentrations, curies released and dose modeling evaluation for these stacks are included in the DOE-HFO annual radionuclide NESHAP report. The sample collection, analyses and emissions estimates for these stacks are outside the scope of HMIS contracted responsibilities and not addressed further in this document.

54 ENVIRONMENTAL SCIENCES↗

TU-A-9A-09: Proton Beam X-Ray Fluorescence CT

Purpose: To evaluate x-ray fluorescence computed tomography induced with proton beams (pXFCT) for imaging of gold contrast agent. Methods: Proton-induced x-ray fluorescence was studied by means of Monte Carlo (MC) simulations using TOPAS, a MC code based on GEANT4. First, proton-induced K-shell and L-shell fluorescence was studied as a function of proton beam energy and 1) depth in water and 2) size of contrast object. Second, pXFCT images of a 2-cm diameter cylindrical phantom with four 5- mm diameter contrast vials and of a 20-cm diameter phantom with 1-cm diameter vials were simulated. Contrast vials were filled with water and water solutions with 1-5% gold per weight. Proton beam energies were varied from 70-250MeV. pXFCT sinograms were generated based on the net number of gold K-shell or L-shell x-rays determined by interpolations from the neighboring 0.5keV energy bins of spectra collected with an idealized 4π detector. pXFCT images were reconstructed with filtered-back projection, and no attenuation correction was applied. Results: Proton induced x-ray fluorescence spectra showed very low background compared to x-ray induced fluorescence. Proton induced L-shell fluorescence had a higher cross-section compared to K-shell fluorescence. Excitation of L-shell fluorescence was most efficient for low-energy protons, i.e. at the Bragg peak. K-shell fluorescence increased with increasing proton beam energy and object size. The 2% and 5% gold contrast vials were accurately reconstructed in K-shell pXFCT images of both the 2-cm and 20-cm diameter phantoms. Small phantom L-shell pXFCT image required attenuation correction and had a higher sensitivity for 70MeV protons compared to 250MeV protons. With attenuation correction, L-shell pXFCT might be a feasible option for imaging of small size (∼2cm) objects. Imaging doses for all simulations were 5-30cGy. Conclusion: Proton induced x-ray fluorescence CT promises to be an alternative quantitative imaging technique to the commonly considered XFCT imaging with x-ray beams.

60 APPLIED LIFE SCIENCES↗

WE-G-9A-01: Radiation Oncology Outcomes Informatics

The construction of databases and support software to enable routine and systematic aggregation, analysis and reporting of patient outcomes data is emerging as an important area. “How have results for our patients been affected by the improvements we have made in our practice and in the technologies we use?” To answer this type of fundamental question about the overall pattern of efficacy observed, it is necessary to systematically gather and analyze data on all patients treated within a clinic. Clinical trials answer, in great depth and detail, questions about outcomes for the subsets of patients enrolled in a given trial. However, routine aggregation and analysis of key treatment parameter data and outcomes information for all patients is necessary to recognize emergent patterns that would be of interest from a public health or practice perspective and could better inform design of clinical trials or the evolution of best practice principals. To address these questions, Radiation Oncology outcomes databases need to be constructed to enable combination essential data from a broad group of data types including: diagnosis and staging, dose volume histogram metrics, patient reported outcomes, toxicity metrics, performance status, treatment plan parameters, demographics, DICOM data and demographics. Developing viable solutions to automate aggregation and analysis of this data requires multidisciplinary efforts to define nomenclatures, modify clinical processes and develop software and database tools requires detailed understanding of both clinical and technical issues. This session will cover the developing area of Radiation Oncology Outcomes Informatics. Learning Objectives: Audience will be able to speak to the technical requirements (software, database, web services) which must be considered in designing an outcomes database. Audience will be able to understand the content and the role of patient reported outcomes as compared to traditional toxicity measures. Audience will be understand approaches, clinical process changes, consensus building efforts and standardizations which must be addressed to succeed in a multi-disciplinary effort to aggregate data for all patients. Audience will be able to discuss technical and process issues related to pooling data among institutions in the context of collaborative studies among the presenting institutions.

60 APPLIED LIFE SCIENCES↗

Technical Note: Development and performance of a software tool for quality assurance of online replanning with a conventional Linac or MR-Linac

Purpose: To develop an integrated quality assurance (QA) software tool for online replanning capable of efficiently and automatically checking radiation treatment (RT) planning parameters and gross plan quality, verifying treatment plan data transfer from treatment planning system (TPS) to record and verify (R&V) system, performing a secondary monitor unit (MU) calculation with or without a presence of a magnetic field from MR-Linac, and validating the delivery record consistency with the plan. Methods: The software tool, named ArtQA, was developed to obtain and compare plan and treatment parameters from both the TPS and the R&V system database. The TPS data are accessed via direct file reading and the R&V data are retrieved via open database connectivity and structured query language. Plan quality is evaluated with both the logical consistency of planning parameters and the achieved dose–volume histograms. Beams in between the TPS and R&V system are matched based on geometry configurations. To consider the effect of a 1.5 T transverse magnetic field from MR-Linac in the secondary MU calculation, a method based on modified Clarkson integration algorithm was developed and tested for a series of clinical situations. Results: ArtQA has been used in their clinic and can quickly detect inconsistencies and deviations in the entire RT planning process. With the use of the ArtQA tool, the efficiency for plan check including plan quality, data transfer, and delivery check can be improved by at least 60%. The newly developed independent MU calculation tool for MR-Linac reduces the difference between the plan and calculated MUs by 10%. Conclusions: The software tool ArtQA can be used to perform a comprehensive QA check from planning to delivery with conventional Linac or MR-Linac and is an essential tool for online replanning where the QA check needs to be performed rapidly.

60 APPLIED LIFE SCIENCES↗

SU-F-T-94: Plan2pdf - a Software Tool for Automatic Plan Report for Philips Pinnacle TPS

Purpose: To implement an automatic electronic PDF plan reporting tool for Philips Pinnacle treatment planning system (TPS) Methods: An electronic treatment plan reporting software is developed by us to enable fully automatic PDF report from Pinnacle TPS to external EMR programs such as MOSAIQ. The tool is named “plan2pdf”. plan2pdf is implemented using Pinnacle scripts, Java and UNIX shell scripts, without any external program needed. plan2pdf supports full auto-mode and manual mode reporting. In full auto-mode, with a single mouse click, plan2pdf will generate a detailed Pinnacle plan report in PDF format, which includes customizable cover page, Pinnacle plan summary, orthogonal views through each plan POI and maximum dose point, DRR for each beam, serial transverse views captured throughout the dose grid at a user specified interval, DVH and scorecard windows. The final PDF report is also automatically bookmarked for each section above for convenient plan review. The final PDF report can either be saved on a user specified folder on Pinnacle, or it can be automatically exported to an EMR import folder via a user configured FTP service. In manual capture mode, plan2pdf allows users to capture any Pinnacle plan by full screen, individual window or rectangular ROI drawn on screen. Furthermore, to avoid possible patients’ plan mix-up during auto-mode reporting, a user conflict check feature is included in plan2pdf: it prompts user to wait if another patient is being exported by plan2pdf by another user. Results: plan2pdf is tested extensively and successfully at our institution consists of 5 centers, 15 dosimetrists and 10 physicists, running Pinnacle version 9.10 on Enterprise servers. Conclusion: plan2pdf provides a highly efficient, user friendly and clinical proven platform for all Philips Pinnacle users, to generate a detailed plan report in PDF format for external EMR systems.

60 APPLIED LIFE SCIENCES↗

Pulmonary Masses: Initial Results of Cone-beam CT Guidance with Needle Planning Software for Percutaneous Lung Biopsy

Purpose: To evaluate the outcome of percutaneous lung biopsy (PLB) findings using cone-beam computed tomographic (CT) guidance (CBCT guidance) and compared to conventional biopsy guidance techniques. Methods: CBCT guidance is a stereotactic technique for needle interventions, combining 3D soft-tissue cone-beam CT, needle planning software, and real-time fluoroscopy. Between March 2007 and August 2010, we performed 84 Tru-Cut PLBs, where bronchoscopy did not provide histopathologic diagnosis. Mean patient age was 64.6 (range 24-85) years; 57 patients were men, and 25 were women. Records were prospectively collected for calculating sensitivity, specificity, positive predictive value, negative predictive value, and accuracy. We also registered fluoroscopy time, room time, interventional time, dose-area product (DAP), and complications. Procedures were divided into subgroups (e.g., location, size, operator). Results: Mean lesion diameter was 32.5 (range 3.0-93.0) mm, and the mean number of samples per biopsy procedure was 3.2 (range 1-7). Mean fluoroscopy time was 161 (range 104-551) s, room time was 34 (range 15-79) min, mean DAP value was 25.9 (range 3.9-80.5) Gy{center_dot}cm{sup -2}, and interventional time was 18 (range 5-65) min. Of 84 lesions, 70 were malignant (83.3%) and 14 were benign (16.7%). Seven (8.3%) of the biopsy samples were nondiagnostic. All nondiagnostic biopsied lesions proved to be malignant during surgical resection. The outcome for sensitivity, specificity, positive predictive value, negative predictive value, and accuracy was 90% (95% confidence interval [CI] 86-96), 100% (95% CI 82-100), 100% (95% CI 96-100), 66.7% (95% CI 55-83), and 91.7% (95% CI 86-96), respectively. Sixteen patients (19%) had minor and 2 (2.4%) had major complications. Conclusion: CBCT guidance is an effective method for PLB, with results comparable to CT/CT fluoroscopy guidance.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

SU-E-J-99: Reconstruction of Cone Beam CT Image Using Volumetric Modulated Arc Therapy Exit Beams

Purpose: To test the possibility of obtaining an image of the treated volume during volumetric modulated arc therapy (VMAT) with exit beams. Method: Using a Varian Clinac 21EX and MVCT detector the following three sets of detector projection data were obtained for cone beam CT reconstruction with and without a Catphan 504 phantom. 1) 72 projection images from 20 × 16 cm{sup 2} open beam with 3 MUs, 2) 72 projection images from 20 × 16 cm{sup 2} MLC closed beam with 14 MUs. 3) 137 projection images from a test RapicArc QA plan. All projection images were obtained in ‘integrated image’ mode. We used OSCaR code to reconstruct the cone beam CT images. No attempts were made to reduce scatter or artifacts. Results: With projection set 1) we obtained a good quality MV CBCT image by optimizing the reconstruction parameters. Using projection set 2) we were not able to obtain a CBCT image of the phantom, which was determined to be due to the variation of interleaf leakage with gantry angle. From projection set 3), we were able to obtain a weak but meaningful signal in the image, especially in the target area where open beam signals were dominant. This finding suggests that one might be able to acquire CBCT images with rough body shape and some details inside the irradiated target area. Conclusion: Obtaining patient images using the VMAT exit beam is challenging but possible. We were able to determine sources of image degradation such as gantry angle dependent interleaf leakage and beams with a large scatter component. We are actively working on improving image quality.

60 APPLIED LIFE SCIENCES↗

WIPP PA Sensitivity Studies in Support of CRA-2014 Completeness Determination and Compliance Decision - 18209

The Waste Isolation Pilot Plant (WIPP) has been developed by the U.S. Department of Energy (DOE) for the geologic (deep underground) disposal of transuranic (TRU) waste. Containment of TRU waste at the WIPP is regulated by the U.S. Environmental Protection Agency (EPA). The DOE demonstrates compliance with the containment requirements by means of performance assessment (PA) calculations. WIPP PA calculations estimate the probability and consequence of potential radionuclide releases from the repository to the accessible environment for a regulatory period of 10,000 years after facility closure. Since TRU waste was first received at the WIPP in 1999, compliance recertification applications (CRAs) have been required by the EPA on five-year cycle. The latest CRA (CRA-2014) was submitted by the DOE to the EPA in 2014. As part of the application, a formal set of PA calculations (CRA-2014 PA) was performed and results were documented in detail. The CRA-2014 PA incorporated several parameter updates based on new data, as well as the implementation of a different model for panel closures, barriers planned for the opening of each waste panel. The results presented as part of the CRA-2014 showed via the required complementary cumulative distribution function (CCDF) release curves that the estimated releases were within compliance limits. As part of their process for reviewing the completeness of the CRA-2014 [1], the EPA formally requested that the DOE perform sensitivity studies based on EPA-requested changes to model parameters. The DOE performed and documented the results of three sensitivity studies described below: CRA14-SEN2 [2], CRA14-SEN3 [3], and CRA14-SEN4 [4]. In each case, the new analysis results were compared to CRA- 2014 PA (CRA14) results to determine the impact of the EPA-requested changes. CRA14-SEN2: the application of EPA-requested modified parameters in the operations and experimental (non-waste) areas of the repository to simulate an accelerated (instantaneous) creep closure, the inclusion of capillary pressure effects on relative permeability, and an increase in initial/residual brine saturation and residual gas saturation. The modifications to the repository model resulted in increased pressures and decreased brine saturations in waste areas and increased pressures and brine saturations in the operations and experimental areas. However, the overall effects on total high-probability mean releases from the repository were entirely insignificant. It was concluded that the modeling assumptions associated with the operations and experimental areas of the repository have an insignificant effect on the prediction of total releases from the repository and/or adequacy of the current (CRA14) model to demonstrate compliance with the regulatory limits. CRA14-SEN3: the application of EPA-requested modified parameters in the panel closure areas and operations and experimental (non-waste) areas of the repository to simulate an accelerated (instantaneous) creep closure, the inclusion of capillary pressure effects on relative permeability, and an increase in initial/residual brine saturation and residual gas saturation. The modifications to the repository model predominantly result in increased pressures and decreased brine saturations in waste areas, increased pressures and brine saturations in the operations and experimental areas, and decreased brine and gas flows across all panel closures. The pressure increases in repository waste regions yielded slightly decreased brine saturations (on average) in those areas. However, the overall effects on total high-probability mean releases from the repository are entirely insignificant. It was concluded that the modeling assumptions made for this sensitivity study which were associated with the panel closures and north end areas of the repository have only a small effect on the prediction of total releases from the repository and/or adequacy of the current (CRA14) model to demonstrate compliance with the regulatory limits. CRA14-SEN4: the application of several changes to the current WIPP PA model (CRA14), including: parameter changes, use of an updated code, and a revised computational grid for the BRAGFLO code. The modifications to the repository model resulted in increased releases in all primary release mechanisms. The impacts of each EPA-requested change to CRA14 were analyzed with respect to each release mechanism in the CRA14-SEN4 study. Overall, total high-probability predicted mean releases from the repository were increased by about 15%. Total low-probability predicted mean releases were increased by about 107%. It was concluded that the EPA-requested changes to the CRA14 result in increases to the predicted total releases from the repository. However, releases calculated in the CRA14-SEN4 analysis remained below regulatory limits, demonstrating continued compliance of the WIPP. In January 2017, the EPA determined that CRA-2014 was complete and then began a technical evaluation of CRA-2014 to determine whether the WIPP continued to comply with the radiation protection standards for disposal. During their evaluation, the EPA utilized the sensitivity study results to inform their ultimate determination in July 2017 that the WIPP continues to comply with regulatory standards. (authors)

12 MANAGEMENT OF RADIOACTIVE AND NON-RADIOACTIVE W↗

Effects of Zr Ion Implantation on Surface Mechanical Properties and Corrosion Resistance of Pure Magnesium

Zirconium (Zr) was implanted into pure Mg by metal vapor vacuum arc (MEVVA) at the dose of 2 × 10{sup 16} ions/cm{sup 2} at room temperature. The surface characteristics of Zr-implanted Mg were analyzed by the Stopping and Range of Ions in Matter software (SRIM) and x-ray photoelectron spectroscopy (XPS), the surface nanohardness and tribological behavior were measured through nanoindentation and a friction-abrasion testing machine, and the corrosion resistance of Zr-implanted Mg was evaluated by electrochemical measurement and immersion test in simulated body fluid (SBF). The results demonstrated that a gradient modified layer composed of MgO, Mg(OH){sub 2}, ZrO{sub 2} and Zr was formed on the near surface of pure Mg and the nanohardness of pure Mg was improved by 48%. Furthermore, the Zr-implanted Mg exhibited a more positive corrosion potential of − 1.43 V (versus SCE) and a lower corrosion current density of 19.9 μA/cm{sup 2}, and localized corrosion was effectively retarded during 24 h immersion in SBF, suggesting that the corrosion resistance of pure Mg was remarkably improved after Zr ion implantation. The mechanisms of surface strengthening and improved corrosion resistance were also discussed in this paper.

36 MATERIALS SCIENCE↗

SU-F-T-310: Does a Head-Mounted Ionization Chamber Detect IMRT Errors?

Purpose: The conventional plan verification strategy is delivering a plan to a QA-phantom before the first treatment. Monitoring each fraction of the patient treatment in real-time would improve patient safety. We evaluated how well a new detector, the IQM (iRT Systems, Germany), is capable of detecting errors we induced into IMRT plans of three different treatment regions. Results were compared to an established phantom. Methods: Clinical plans of a brain, prostate and head-and-neck patient were modified in the Pinnacle planning system, such that they resulted in either several percent lower prescribed doses to the target volume or several percent higher doses to relevant organs at risk. Unaltered plans were measured on three days, modified plans once, each with the IQM at an Elekta Synergy with an Agility MLC. All plans were also measured with the ArcCHECK with the cavity plug and a PTW semiflex 31010 ionization chamber inserted. Measurements were evaluated with SNC patient software. Results: Repeated IQM measurements of the original plans were reproducible, such that a 1% deviation from the mean as warning and 3% as action level as suggested by the manufacturer seemed reasonable. The IQM detected most of the simulated errors including wrong energy, a faulty leaf, wrong trial exported and a 2 mm shift of one leaf bank. Detection limits were reached for two plans - a 2 mm field position error and a leaf bank offset combined with an MU change. ArcCHECK evaluation according to our current standards also left undetected errors. Ionization chamber evaluation alone would leave most errors undetected. Conclusion: The IQM detected most errors and performed as well as currently established phantoms with the advantage that it can be used throughout the whole treatment. Drawback is that it does not indicate the source of the error.

60 APPLIED LIFE SCIENCES↗